Evidence map›Paper›PMID 33754161›Full record

ArticleExperimental brain research2021

Mdivi-1 alleviates brain damage and synaptic dysfunction after intracerebral hemorrhage in mice.

Yunge Zhang, Tongyu Rui, Chengliang Luo, Qianqian Li

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental brain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yunge ZhangInstitute of Forensic Science, Changzhou De'an Hospital, Changzhou, 213003, Jiangsu, China.
Tongyu RuiDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Chengliang LuoDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, 215123, Jiangsu, China. clluo@suda.edu.cn.ORCID http://orcid.org/0000-0002-2055-3660
Qianqian LiSchool of Forensic Medicine, Wannan Medical College, Wuhu, 241002, Anhui, China. bzliqian@126.com.
Soochow University · CNInstitute of Forensic Science · CNWannan Medical College · CN

Funding

National Natural Science Foundation of China 81400999National Natural Science Foundation of China 81971163Priority Academic Program Development of Jiangsu Higher Education Institutions PAPDSuzhou Municipal Science and Technology Bureau SYS2019027
6 · The paper itself

Abstract

As a selective inhibitor of mitochondrial fission protein dynamin-related protein-1 (Drp1), mitochondrial division inhibitor 1 (mdivi-1) can cross the blood-brain barrier (BBB) and exert neuroprotection. However, it remains unclear whether mdivi-1 can attenuate intracerebral hemorrhage (ICH)-induced secondary brain injury. This study was undertaken to characterize the roles of mdivi-1 in short-term and long-term behavioral outcomes, along with synaptic plasticity changes in mice after ICH. The results indicated mdivi-1 reversed Drp1 translocation and the morphologic changes of mitochondria, as well as ameliorated short-term neurobehavioral deficits, the BBB disruption and brain edema remarkably. In addition, mdivi-1 could rescue ICH-induced motor and memory dysfunctions. Mdivi-1 could also prevent ICH-induced reductions in synaptic proteins (synapsin I, PSD95) and phosphorylated cAMP-response element binding (p-CREB). In vitro, mdivi-1 inhibited hemin-induced hippocampal neuron death and improved neurite outgrowth. In conclusion, we found that mdivi-1 can alleviate short-term and long-term neurological deficits, synaptic dysfunction. These findings demonstrate that mdivi-1 may be beneficial in the treatment of secondary brain injury, synaptic dysfunction and neurological outcomes caused by ICH.

Indexed as

Brain InjuriesQuinazolinonesAnimalsBlood-Brain BarrierCerebral HemorrhageMiceMitochondrial DynamicsQuinazolinonesCognitive impairmentDynamin-related protein-1 (Drp1)Intracerebral hemorrhage (ICH)Mdivi-1Synaptic dysfunction

Identifiers

PMID33754161
OpenAlexW3137346104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.